Clinical Trial Update: TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial TREE-2 evaluated three regimens of Eloxatin (oxaliplatin) in patients with advanced colorectal cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED